Judy 🫘
@jbvienna.bsky.social
🫘 Nephrology resident in Austria
Interested in palliative care
Hobbies: 🇯🇵🎻🎤📚
Interested in palliative care
Hobbies: 🇯🇵🎻🎤📚
Reposted by Judy 🫘
Some interesting insights here, including that people are much more influenced by *people they follow* switching platforms than by their own *followers* switching platforms.
Preprint: "Why Academics are Leaving Twitter for Bluesky" arxiv.org/abs/2505.24801
Preprint: "Why Academics are Leaving Twitter for Bluesky" arxiv.org/abs/2505.24801
June 2, 2025 at 7:26 PM
Some interesting insights here, including that people are much more influenced by *people they follow* switching platforms than by their own *followers* switching platforms.
Preprint: "Why Academics are Leaving Twitter for Bluesky" arxiv.org/abs/2505.24801
Preprint: "Why Academics are Leaving Twitter for Bluesky" arxiv.org/abs/2505.24801
Reposted by Judy 🫘
Delivery of Palliative Care in the Last Year of Life to Individuals Receiving Maintenance Dialysis: A Population-Level Cross-Sectional Study
bit.ly/Bonares25OI #OpenAccess
#CKD
bit.ly/Bonares25OI #OpenAccess
#CKD
August 18, 2025 at 4:04 PM
Delivery of Palliative Care in the Last Year of Life to Individuals Receiving Maintenance Dialysis: A Population-Level Cross-Sectional Study
bit.ly/Bonares25OI #OpenAccess
#CKD
bit.ly/Bonares25OI #OpenAccess
#CKD
Reposted by Judy 🫘
(Basic) ICU Hemodynamic “Secrets” - Part1:
I know you know them, but let’s remind ourselves of some basic hemodynamic "secrets":
I know you know them, but let’s remind ourselves of some basic hemodynamic "secrets":
August 16, 2025 at 6:23 PM
(Basic) ICU Hemodynamic “Secrets” - Part1:
I know you know them, but let’s remind ourselves of some basic hemodynamic "secrets":
I know you know them, but let’s remind ourselves of some basic hemodynamic "secrets":
Reposted by Judy 🫘
New Commentary by Madhumitha Rajagopal on the #AJKDBlog:
Unseen, Unheard: The Silent Strain on Dialysis Caregivers bit.ly/RajagopalBlog (FREE)
Article by Driehuis et al: bit.ly/Driehuis25OI
Unseen, Unheard: The Silent Strain on Dialysis Caregivers bit.ly/RajagopalBlog (FREE)
Article by Driehuis et al: bit.ly/Driehuis25OI
August 14, 2025 at 10:01 AM
New Commentary by Madhumitha Rajagopal on the #AJKDBlog:
Unseen, Unheard: The Silent Strain on Dialysis Caregivers bit.ly/RajagopalBlog (FREE)
Article by Driehuis et al: bit.ly/Driehuis25OI
Unseen, Unheard: The Silent Strain on Dialysis Caregivers bit.ly/RajagopalBlog (FREE)
Article by Driehuis et al: bit.ly/Driehuis25OI
Reposted by Judy 🫘
P-values are fraught with hazard, but SO IS BAYESIAN STATISTICS
the Achilles heel of Bayesian stats is that someone determines a pre-test probability distribution (usually arbitrarily)
The pre-test probability is often too high
This inflates the final posterior probability
🧵 #1/4 #EMIMCC
the Achilles heel of Bayesian stats is that someone determines a pre-test probability distribution (usually arbitrarily)
The pre-test probability is often too high
This inflates the final posterior probability
🧵 #1/4 #EMIMCC
August 14, 2025 at 12:10 PM
P-values are fraught with hazard, but SO IS BAYESIAN STATISTICS
the Achilles heel of Bayesian stats is that someone determines a pre-test probability distribution (usually arbitrarily)
The pre-test probability is often too high
This inflates the final posterior probability
🧵 #1/4 #EMIMCC
the Achilles heel of Bayesian stats is that someone determines a pre-test probability distribution (usually arbitrarily)
The pre-test probability is often too high
This inflates the final posterior probability
🧵 #1/4 #EMIMCC
Reposted by Judy 🫘
Health Outcome Preferences and Trade-Offs Among Older Adults With Advanced CKD: A Discrete Choice Experiment
bit.ly/Schoot25OI #OpenAccess
#CKD
bit.ly/Schoot25OI #OpenAccess
#CKD
August 11, 2025 at 4:04 PM
Health Outcome Preferences and Trade-Offs Among Older Adults With Advanced CKD: A Discrete Choice Experiment
bit.ly/Schoot25OI #OpenAccess
#CKD
bit.ly/Schoot25OI #OpenAccess
#CKD
August 8, 2025 at 3:26 PM
Reposted by Judy 🫘
Editorial by Marie Evans, Jenny Lindberg, and Johan Sundelöf:
Finding Barriers for the Implementation of Advanced Care Planning in Patients Receiving Dialysis
bit.ly/AJKD25EvansED (FREE)
Finding Barriers for the Implementation of Advanced Care Planning in Patients Receiving Dialysis
bit.ly/AJKD25EvansED (FREE)
July 23, 2025 at 10:01 AM
Editorial by Marie Evans, Jenny Lindberg, and Johan Sundelöf:
Finding Barriers for the Implementation of Advanced Care Planning in Patients Receiving Dialysis
bit.ly/AJKD25EvansED (FREE)
Finding Barriers for the Implementation of Advanced Care Planning in Patients Receiving Dialysis
bit.ly/AJKD25EvansED (FREE)
Reposted by Judy 🫘
NEW on the #AJKDBlog:
@maximalchange.bsky.social interviews the authors of a recent review of ADPKD, Sara S. Jdiaa and Reem A. Mustafa, and discusses prognosis, goals, and monitoring.
bit.ly/Jdiaa25 (FREE)
@maximalchange.bsky.social interviews the authors of a recent review of ADPKD, Sara S. Jdiaa and Reem A. Mustafa, and discusses prognosis, goals, and monitoring.
bit.ly/Jdiaa25 (FREE)
July 19, 2025 at 4:02 PM
NEW on the #AJKDBlog:
@maximalchange.bsky.social interviews the authors of a recent review of ADPKD, Sara S. Jdiaa and Reem A. Mustafa, and discusses prognosis, goals, and monitoring.
bit.ly/Jdiaa25 (FREE)
@maximalchange.bsky.social interviews the authors of a recent review of ADPKD, Sara S. Jdiaa and Reem A. Mustafa, and discusses prognosis, goals, and monitoring.
bit.ly/Jdiaa25 (FREE)
Reposted by Judy 🫘
‘ Strawberry milkshake ´ dialysate in a Peritoneal Dialysis patient at PD onset ? What is your diagnosis ?
➡️ authors.elsevier.com/a/1lSI0_1y3u...
@inesdufour.bsky.social @clemencebechade.bsky.social @lobbedezt.bsky.social @hswapnil.medsky.social @kidneyint.bsky.social
➡️ authors.elsevier.com/a/1lSI0_1y3u...
@inesdufour.bsky.social @clemencebechade.bsky.social @lobbedezt.bsky.social @hswapnil.medsky.social @kidneyint.bsky.social
July 18, 2025 at 10:39 AM
‘ Strawberry milkshake ´ dialysate in a Peritoneal Dialysis patient at PD onset ? What is your diagnosis ?
➡️ authors.elsevier.com/a/1lSI0_1y3u...
@inesdufour.bsky.social @clemencebechade.bsky.social @lobbedezt.bsky.social @hswapnil.medsky.social @kidneyint.bsky.social
➡️ authors.elsevier.com/a/1lSI0_1y3u...
@inesdufour.bsky.social @clemencebechade.bsky.social @lobbedezt.bsky.social @hswapnil.medsky.social @kidneyint.bsky.social
Reposted by Judy 🫘
Long-term Outcome of #Adult Patients With #Membranous Nephropathy Treated With #Rituximab
#VisualAbstract by @priti899.bsky.social
www.kireports.org/ar...
#VisualAbstract by @priti899.bsky.social
www.kireports.org/ar...
July 14, 2025 at 3:00 PM
Long-term Outcome of #Adult Patients With #Membranous Nephropathy Treated With #Rituximab
#VisualAbstract by @priti899.bsky.social
www.kireports.org/ar...
#VisualAbstract by @priti899.bsky.social
www.kireports.org/ar...
Reposted by Judy 🫘
Review by Anjana Gopal, Janine Farragher, Sarbjit V. Jassal, and Istvan Mucsi:
Sleep Disorders in CKD
bit.ly/GopalREV25 (FREE)
Sleep Disorders in CKD
bit.ly/GopalREV25 (FREE)
July 11, 2025 at 10:03 PM
Review by Anjana Gopal, Janine Farragher, Sarbjit V. Jassal, and Istvan Mucsi:
Sleep Disorders in CKD
bit.ly/GopalREV25 (FREE)
Sleep Disorders in CKD
bit.ly/GopalREV25 (FREE)
July 9, 2025 at 11:40 AM
Reposted by Judy 🫘
🎨Check out the beautiful #visualabstract by #NephJC intern @shelliefravel.bsky.social
⏰Chat happening on July 8, 9 pm EST
www.nephjc.com/news/2025/7/...
⏰Chat happening on July 8, 9 pm EST
www.nephjc.com/news/2025/7/...
CONFIDENCE Visual Abstract — NephJC
Check out the beautiful visual abstract made by NephJC intern Michelle Fravel .
www.nephjc.com
July 7, 2025 at 8:00 PM
🎨Check out the beautiful #visualabstract by #NephJC intern @shelliefravel.bsky.social
⏰Chat happening on July 8, 9 pm EST
www.nephjc.com/news/2025/7/...
⏰Chat happening on July 8, 9 pm EST
www.nephjc.com/news/2025/7/...
Reposted by Judy 🫘
The trend in the US was to start at higher GFRs throughout the 2000s and this peaked in 2010 and since then there has been a small decline in mean GFR at initiation but imo it is still too high.
July 6, 2025 at 1:05 PM
The trend in the US was to start at higher GFRs throughout the 2000s and this peaked in 2010 and since then there has been a small decline in mean GFR at initiation but imo it is still too high.
Reposted by Judy 🫘
Interesting data from Alberta
www.kidney-international.org/article/S008... in @kidneyint.bsky.social
GFR < 15 is classified as ‘kidney failure’ in most studies - but about a third of them die before starting RRT.
Is that glass half full or half empty? 🥃
#NephSky
www.kidney-international.org/article/S008... in @kidneyint.bsky.social
GFR < 15 is classified as ‘kidney failure’ in most studies - but about a third of them die before starting RRT.
Is that glass half full or half empty? 🥃
#NephSky
July 6, 2025 at 12:37 AM
Interesting data from Alberta
www.kidney-international.org/article/S008... in @kidneyint.bsky.social
GFR < 15 is classified as ‘kidney failure’ in most studies - but about a third of them die before starting RRT.
Is that glass half full or half empty? 🥃
#NephSky
www.kidney-international.org/article/S008... in @kidneyint.bsky.social
GFR < 15 is classified as ‘kidney failure’ in most studies - but about a third of them die before starting RRT.
Is that glass half full or half empty? 🥃
#NephSky
Reposted by Judy 🫘
➡️ Cognitive impairment and physical dysfunction associated with unplanned dialysis initiation www.kireports.org/ar...
July 4, 2025 at 12:00 PM
➡️ Cognitive impairment and physical dysfunction associated with unplanned dialysis initiation www.kireports.org/ar...
Reposted by Judy 🫘
In the latest video in our partnership with @glaucomflecken.bsky.social, the REGENCY trial investigating the efficacy and safety of obinutuzumab when added to standard therapy in patients with active proliferative lupus nephritis is explained. Access the article for free: nej.md/DrG20
July 1, 2025 at 7:04 PM
In the latest video in our partnership with @glaucomflecken.bsky.social, the REGENCY trial investigating the efficacy and safety of obinutuzumab when added to standard therapy in patients with active proliferative lupus nephritis is explained. Access the article for free: nej.md/DrG20
Reposted by Judy 🫘
Summary: urinary anion gap is not a good measure of urine ammonium and should be abandoned.
If you need to know the urinary ammonium, measure the urinary ammonium.
15/15
If you need to know the urinary ammonium, measure the urinary ammonium.
15/15
November 25, 2024 at 2:54 AM
Summary: urinary anion gap is not a good measure of urine ammonium and should be abandoned.
If you need to know the urinary ammonium, measure the urinary ammonium.
15/15
If you need to know the urinary ammonium, measure the urinary ammonium.
15/15
Reposted by Judy 🫘
Determinants of Caregiver Burden Among Spouses of Patients With Kidney Failure: A Qualitative Study
bit.ly/42kNvWq #OpenAccess
#VisualAbstract
bit.ly/42kNvWq #OpenAccess
#VisualAbstract
June 21, 2025 at 10:01 PM
Determinants of Caregiver Burden Among Spouses of Patients With Kidney Failure: A Qualitative Study
bit.ly/42kNvWq #OpenAccess
#VisualAbstract
bit.ly/42kNvWq #OpenAccess
#VisualAbstract
Reposted by Judy 🫘
GLP-1 Receptor Agonist Outcomes, Safety, and BMI Change in a National Cohort of Dialysis Patients by Drs. Orandi, McAdams-DeMarco et al.
journals.lww.com/cjasn/abstra...
GLP-1 RA use in DM 2 patients on HD was associated with weight loss, reduced mortality, higher chance of waitlisting.
journals.lww.com/cjasn/abstra...
GLP-1 RA use in DM 2 patients on HD was associated with weight loss, reduced mortality, higher chance of waitlisting.
June 19, 2025 at 5:09 PM
GLP-1 Receptor Agonist Outcomes, Safety, and BMI Change in a National Cohort of Dialysis Patients by Drs. Orandi, McAdams-DeMarco et al.
journals.lww.com/cjasn/abstra...
GLP-1 RA use in DM 2 patients on HD was associated with weight loss, reduced mortality, higher chance of waitlisting.
journals.lww.com/cjasn/abstra...
GLP-1 RA use in DM 2 patients on HD was associated with weight loss, reduced mortality, higher chance of waitlisting.
Reposted by Judy 🫘
#POCUS in #Nephrology: Enthusiasm Alone Won't Suffice; Training Is Key".
@ajkd.bsky.social
The final typeset version is out. Here is the open access link 🔗 authors.elsevier.com/a/1lFg5_6ClS...
#Nephpearls #FOAMed
@ajkd.bsky.social
The final typeset version is out. Here is the open access link 🔗 authors.elsevier.com/a/1lFg5_6ClS...
#Nephpearls #FOAMed
June 13, 2025 at 11:17 AM
#POCUS in #Nephrology: Enthusiasm Alone Won't Suffice; Training Is Key".
@ajkd.bsky.social
The final typeset version is out. Here is the open access link 🔗 authors.elsevier.com/a/1lFg5_6ClS...
#Nephpearls #FOAMed
@ajkd.bsky.social
The final typeset version is out. Here is the open access link 🔗 authors.elsevier.com/a/1lFg5_6ClS...
#Nephpearls #FOAMed
Reposted by Judy 🫘
The rate of procedures for maintaining hemodialysis vascular access in new patients is 0.71 per year, with higher risks in adults with a primary central venous catheter. kidney.pub/KID0841
#ASNKidney360
#ASNKidney360
June 12, 2025 at 6:30 PM
The rate of procedures for maintaining hemodialysis vascular access in new patients is 0.71 per year, with higher risks in adults with a primary central venous catheter. kidney.pub/KID0841
#ASNKidney360
#ASNKidney360